These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
124 related items for PubMed ID: 2839472
1. Increased steady-state levels of laminin B1 mRNA in kidneys of long-term streptozotocin-diabetic rats. No effect of an aldose reductase inhibitor. Poulsom R, Kurkinen M, Prockop DJ, Boot-Handford RP. J Biol Chem; 1988 Jul 25; 263(21):10072-6. PubMed ID: 2839472 [Abstract] [Full Text] [Related]
2. Altered steady-state mRNA levels of basement membrane proteins in diabetic mouse kidneys and thromboxane synthase inhibition. Ledbetter S, Copeland EJ, Noonan D, Vogeli G, Hassell JR. Diabetes; 1990 Feb 25; 39(2):196-203. PubMed ID: 2227127 [Abstract] [Full Text] [Related]
3. Steady-state levels of mRNAs coding for the type IV collagen and laminin polypeptide chains of basement membranes exhibit marked tissue-specific stoichiometric variations in the rat. Boot-Handford RP, Kurkinen M, Prockop DJ. J Biol Chem; 1987 Sep 15; 262(26):12475-8. PubMed ID: 3624269 [Abstract] [Full Text] [Related]
4. Axonal transport and tissue contents of substance P in rats with long-term streptozotocin-diabetes. Effects of the aldose reductase inhibitor 'statil'. Robinson JP, Willars GB, Tomlinson DR, Keen P. Brain Res; 1987 Nov 24; 426(2):339-48. PubMed ID: 2446712 [Abstract] [Full Text] [Related]
5. Reduced anterograde and retrograde accumulation of axonally transported phosphofructokinase in streptozotocin-diabetic rats: effects of insulin and the aldose reductase inhibitor 'Statil'. Willars GB, Calcutt NA, Tomlinson DR. Diabetologia; 1987 Apr 24; 30(4):239-43. PubMed ID: 2439402 [Abstract] [Full Text] [Related]
6. Kidney levels of mRNA encoding S and B2 laminin and alpha 1 (IV) collagen in diabetic rats fed an aldose reductase inhibitor. Patel BN, Boot-Handford RP. Biochem Soc Trans; 1991 Nov 24; 19(4):367S. PubMed ID: 1794501 [No Abstract] [Full Text] [Related]
7. Studies on peripheral nerve and lens in long-term experimental diabetes: effects of the aldose reductase inhibitor statil. Willars GB, Townsend J, Tomlinson DR, Compton AM, Churchill RD. Metabolism; 1988 May 24; 37(5):442-9. PubMed ID: 2452959 [Abstract] [Full Text] [Related]
8. Muscarinic receptor density is reduced in diabetic rat atria, an effect prevented by the aldose reductase inhibitor, Statil. Kofo-Abayomi A, Lucas PD. J Pharm Pharmacol; 1987 Dec 24; 39(12):1019-21. PubMed ID: 2894428 [Abstract] [Full Text] [Related]
9. No influence of an aldose reductase inhibitor on glycogen deposition in tubules from streptozotocin diabetic rats. Rasch R, Osterby R. J Diabet Complications; 1989 Dec 24; 3(4):198-201. PubMed ID: 2533211 [Abstract] [Full Text] [Related]
10. Treatment with an aldose reductase inhibitor can reduce the susceptibility of fast axonal transport following nerve compression in the streptozotocin-diabetic rat. Dahlin LB, Archer DR, McLean WG. Diabetologia; 1987 Jun 24; 30(6):414-8. PubMed ID: 2445613 [Abstract] [Full Text] [Related]
11. Glomerular basement membrane thickening in streptozotocin diabetic rats despite treatment with an aldose reductase inhibitor. Osterby R, Gundersen HJ. J Diabet Complications; 1989 Jun 24; 3(3):149-53. PubMed ID: 2528558 [Abstract] [Full Text] [Related]
12. Increases in collagen type IV and laminin in galactose-induced retinal capillary basement membrane thickening--prevention by an aldose reductase inhibitor. Das A, Frank RN, Zhang NL, Samadani E. Exp Eye Res; 1990 Mar 24; 50(3):269-80. PubMed ID: 2108050 [Abstract] [Full Text] [Related]
13. The effect of aldose reductase inhibitor Statil (ICI 128436) on the glucose over-utilization in kidney of diabetic rats. Sochor M, Kunjara S, McLean P. Biochem Pharmacol; 1988 Sep 01; 37(17):3349-56. PubMed ID: 2969732 [Abstract] [Full Text] [Related]
14. Sorbitol metabolism in the retina, optic nerve, and sural nerve of diabetic rats treated with an aldose reductase inhibitor. Naeser P, Brolin SE, Eriksson UJ. Metabolism; 1988 Dec 01; 37(12):1143-5. PubMed ID: 3143049 [Abstract] [Full Text] [Related]
15. Fast anterograde axonal transport in wasted and non-wasted diabetic rats; effects of aldose reductase inhibition. Whiteley SJ, Townsend J, Tomlinson DR, Willars GB. Diabetes Res; 1986 Nov 01; 3(9):447-52. PubMed ID: 2435444 [Abstract] [Full Text] [Related]
16. The effect of aldose reductase inhibitor, statil, on hyperpermeability of iridial vessels in experimental galactosemic rats. Terubayashi H, Akagi Y. Jpn J Ophthalmol; 1989 Nov 01; 33(3):343-7. PubMed ID: 2507812 [Abstract] [Full Text] [Related]
17. Properties of ICI 128,436, a novel aldose reductase inhibitor, and its effects on diabetic complications in the rat. Stribling D, Mirrlees DJ, Harrison HE, Earl DC. Metabolism; 1985 Apr 01; 34(4):336-44. PubMed ID: 3920474 [Abstract] [Full Text] [Related]
18. Changes in steady-state levels of mRNAs coding for type IV collagen, laminin and fibronectin following capillary basement membrane thickening in human adult onset diabetes. Kolbe M, Kaufman JL, Friedman J, Dinerstein C, Mackenzie JW, Boyd CD. Connect Tissue Res; 1990 Apr 01; 25(1):77-85. PubMed ID: 2245601 [Abstract] [Full Text] [Related]